{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Helicobacter pylori", "PHG", "gastric biopsy", "histopathology", "liver cirrhosis", "prevalence"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35801205", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "17"}], "Language": ["eng"], "ELocationID": ["902255", "10.3389/fmed.2022.902255"], "Journal": {"ISSN": "2296-858X", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in medicine", "ISOAbbreviation": "Front Med (Lausanne)"}, "ArticleTitle": "<i>Helicobacter pylori</i> Infection in Cirrhotic Patients With Portal Hypertensive Gastropathy: A New Enigma?", "Pagination": {"StartPage": "902255", "MedlinePgn": "902255"}, "Abstract": {"AbstractText": ["The relationship between <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection and Portal hypertensive gastropathy (PHG) is still a debatable matter. The aim of this study is to find out how common <i>H. pylori</i> infection is in cirrhotic patients with PHG and to see if there's a link between <i>H. pylori</i> infection and PHG severity. Out of 340 cirrhotic patients who had upper Gastrointestinal Tract (GIT) endoscopy for early varices screening, 160 cirrhotic patients were selected and divided into 2 groups; 80 cirrhotic patients with PHG (cases) and 80 cirrhotic patients without PHG (controls). Gastric biopsies were taken from all enrolled patients for histological evaluation for the presence or absence of <i>H. pylori</i> infection. <i>H. pylori</i> was found in 44 cirrhotic patients (55%) who had PHG (cases), compared to 22 cirrhotic patients (27.5%) who did not have PHG (controls). The prevalence of <i>H. pylori</i> infection was significantly higher in patients with PHG (<i>p</i> < 0.001). The severity of PHG was associated with <i>H. pylori</i> infection (<i>p</i> < 0.001). The response to eradication therapy of <i>H. pylori</i> infection was must better in patients without PHG (<i>p</i> = 0.045). By multi-variant analysis, <i>H. pylori</i> infection, splenic diameter, and portal vein diameter were independent predictors for PHG presence. After treating <i>H. pylori</i> infection in patients who tested positive for <i>H. pylori</i>, there was a significant reduction in PHG severity (<i>p</i> < 0.001). Patients with PHG have a greater prevalence of <i>H. pylori</i> infection. PHG is more severe in patients infected with <i>H. pylori</i>. To improve PHG severity, cirrhotic patients must have their <i>H. pylori</i> infection eradicated."], "CopyrightInformation": "Copyright \u00a9 2022 Alarfaj, Abdallah Mostafa, Abdelsalam, Negm, El-Masry, Hussein and El Nakib."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia."}], "LastName": "Alarfaj", "ForeName": "Sumaiah J", "Initials": "SJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt."}], "LastName": "Abdallah Mostafa", "ForeName": "Sally", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt."}], "LastName": "Abdelsalam", "ForeName": "Ramy A", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta, Egypt."}], "LastName": "Negm", "ForeName": "Walaa A", "Initials": "WA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt."}], "LastName": "El-Masry", "ForeName": "Thanaa A", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Hussein", "ForeName": "Ismail A", "Initials": "IA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Tropical Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt."}], "LastName": "El Nakib", "ForeName": "Ahmed Mohamed", "Initials": "AM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Med (Lausanne)", "NlmUniqueID": "101648047", "ISSNLinking": "2296-858X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Holland-Bill L, Christiansen C, Gammelager H, Mortensen R, Pedersen L, S\u00f8rensen H. Chronic liver disease and 90-day mortality in 21 359 patients following peptic ulcer bleeding\u2013a nationwide cohort study. Aliment Pharmacol Ther. (2015) 41:564\u201372. 10.1111/apt.13073", "ArticleIdList": ["10.1111/apt.13073", "25588862"]}, {"Citation": "Alotaibi B, Mokhtar FA, El-Masry TA, Elekhnawy E, Mostafa SA, Abdelkader DH, et al. Antimicrobial activity of Brassica rapa L. Flowers extract on gastrointestinal tract infections and antiulcer potential against indomethacin-induced gastric ulcer in rats supported by metabolomics profiling. J Inflamm Res. (2021) 14:7411. 10.2147/JIR.S345780", "ArticleIdList": ["10.2147/JIR.S345780", "PMC8721290", "35002276"]}, {"Citation": "Sarin SK, Shahi HM, Jain M, Jain AK, Issar SK, Murthy NS. The natural history of portal hypertensive gastropathy: influence of variceal eradication. Am J Gastroenterol. (2000) 95:2888\u201393. 10.1111/j.1572-0241.2000.03200.x", "ArticleIdList": ["10.1111/j.1572-0241.2000.03200.x", "11051364"]}, {"Citation": "Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. Gastroenterology. (2000) 119:181\u20137.", "ArticleIdList": ["10889167"]}, {"Citation": "Merli M, Nicolini G, Angeloni S, Gentili F, Attili AF, Riggio O. The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am Coll Gastroenterol. (2004) 99:1959\u201365. 10.1111/j.1572-0241.2004.40246.x", "ArticleIdList": ["10.1111/j.1572-0241.2004.40246.x", "15447756"]}, {"Citation": "Thuluvath PJ, Yoo HY. Portal hypertensive gastropathy. Am J Gastroenterol. (2002) 97:2973\u20138.", "ArticleIdList": ["12492178"]}, {"Citation": "Papazian A, Braillon A, Dupas J, Sevenet F, Capron J. Portal hypertensive gastric mucosa: an endoscopic study. Gut. (1986) 27:1199\u2013203.", "ArticleIdList": ["PMC1433869", "3781334"]}, {"Citation": "Cal\u00e9s P, Zabotto B, Meskens C, Caucanas J-P, Vinel J-P, Desmorat H, et al. Gastroesophageal endoscopic features in cirrhosis: observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology. (1990) 98:156\u201362.", "ArticleIdList": ["2293575"]}, {"Citation": "Dore M, Mura D, Deledda S, Maragkoudakis E, Pironti A, Realdi G. Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role of Helicobacter pylori infection and portal hypertensive gastropathy. Can J Gastroenterol. (2004) 18:521\u20134. 10.1155/2004/150674", "ArticleIdList": ["10.1155/2004/150674", "15372116"]}, {"Citation": "Vergara M, Calvet X, Roqu\u00e9 M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol. (2002) 14:717\u201322.", "ArticleIdList": ["12169979"]}, {"Citation": "Al Mofleh IA. Does Helicobacter pylori affect portal hypertensive gastropathy? Saudi J Gastroenterol. (2007) 13:95. 10.4103/1319-3767.32186", "ArticleIdList": ["10.4103/1319-3767.32186", "19858622"]}, {"Citation": "Eid KA, Shawky MA, Hassan AM, Mohammed AQ, Mohammed MI. Prevalence of Helicobacter pylori infection in patients with portal hypertensive gastropathy owing to liver cirrhosis in upper Egypt. Al-Azhar Assiut Med J. (2016) 14:109."}, {"Citation": "Fontana RJ, Sanyal AJ, Mehta S, Doherty MC, Neuschwander-Tetri BA, Everson GT, et al. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am Coll Gastroenterol. (2006) 101:983\u201392. 10.1111/j.1572-0241.2006.00461.x", "ArticleIdList": ["10.1111/j.1572-0241.2006.00461.x", "16573786"]}, {"Citation": "Kawanaka H, Tomikawa M, Jones MK, Szabo IL, Pai R, Baatar D, et al. Defective mitogen-activated protein kinase (ERK2) signaling in gastric mucosa of portal hypertensive rats: potential therapeutic implications. Hepatology. (2001) 34:990\u20139. 10.1053/jhep.2001.28507", "ArticleIdList": ["10.1053/jhep.2001.28507", "11679970"]}, {"Citation": "Pan W-D, Xun R-Y, Chen Y-M. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors. Hepatobiliary Pancreat Dis Int. (2002) 1:527\u201331.", "ArticleIdList": ["14607680"]}, {"Citation": "Patel MK, Trombly MI, Kurt-Jones EA. Innate immune responses to Helicobacter pylori infection: an overview. Methods Mol Biol. (2012) 921:205\u20137.", "ArticleIdList": ["23015506"]}, {"Citation": "Tanoue K, Hashizume M, Wada H, Ohta M, Kitano S, Sugimachi K. Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study. Gastroint Endosc. (1992) 38:582\u20135. 10.1016/s0016-5107(92)70522-7", "ArticleIdList": ["10.1016/s0016-5107(92)70522-7", "1397916"]}, {"Citation": "Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am Coll Gastroenterol. (2017) 112:212\u201339.", "ArticleIdList": ["28071659"]}, {"Citation": "Chung WJ. Management of portal hypertensive gastropathy and other bleeding. Clin Mol Hepatol. (2014) 20:1. 10.3350/cmh.2014.20.1.1", "ArticleIdList": ["10.3350/cmh.2014.20.1.1", "PMC3992324", "24757652"]}, {"Citation": "Safwat E, Hussein HA, Hakim SA. Helicobacter pylori in Egyptian patients with HCV-related liver cirrhosis and portal hypertensive gastropathy: prevalence and relation to disease severity. Life Sci J. (2015) 12:168\u201373."}, {"Citation": "Abbas Z, Yakoob J, Usman MW, Shakir T, Hamid S, Jafri W. Effect of Helicobacter pylori and its virulence factors on portal hypertensive gastropathy and interleukin (IL)-8, IL-10, and tumor necrosis factor-alpha levels. Saudi J Gastroenterol. (2014) 20:120. 10.4103/1319-3767.129477", "ArticleIdList": ["10.4103/1319-3767.129477", "PMC3987152", "24705150"]}, {"Citation": "Kim DJ, Kim HY, Kim SJ, Hahn TH, Jang MK, Baik GH, et al. Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis. Korean J Intern Med. (2008) 23:16.", "ArticleIdList": ["PMC2686959", "18363275"]}, {"Citation": "El-Toukhy N, Omar El-Farouk L, Youssef M. Helicobacter pylori infection is associated with portal\u0131 hypertensive gastropathy in patients with liver cirrhosis\u0131. Afro Egypt J Infect Endem Dis. (2021) 11:61\u20138."}, {"Citation": "El-Masry S, El-Shahat M, Badra G, Aboel-Nour MF, Lotfy M. Helicobacter pylori and hepatitis C virus coinfection in Egyptian patients. J Glob Infect Dis. (2010) 2:4. 10.4103/0974-777X.59244", "ArticleIdList": ["10.4103/0974-777X.59244", "PMC2840963", "20300411"]}, {"Citation": "Nashaat EH, Abd-Elaziz H, Sabry M, Ibrahim A. Non-endoscopic predictors of esophageal varices and portal hypertensive gastropathy. Nat Sci. (2010) 8:43\u201350."}, {"Citation": "Zardi EM, Ghittoni G, Margiotta D, Viera FT, Di Matteo F, Rossi S. Portal hypertensive gastropathy in cirrhotics without varices: a case\u2013control study. Eur J Gastroenterol Hepatol. (2015) 27:91\u20136. 10.1097/MEG.0000000000000234", "ArticleIdList": ["10.1097/MEG.0000000000000234", "25386762"]}, {"Citation": "Sathar SA, Kunnathuparambil SG, Sreesh S, Narayanan P, Vinayakumar KR. Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy. Ann Gastroenterol. (2014) 27:48.", "ArticleIdList": ["PMC3959527", "24714519"]}, {"Citation": "Hammad OM, Abu-Seif MA, Ashour M, Hifnawy T. Correlation of portal hypertensive gastropathy with Helicobacter pylori infection, liver dysfunction, hypersplenism and oesophageal varices. Med J Cairo Univ. (2009) 77:597\u2013601."}, {"Citation": "Hu J-K, Li X-M, Gu B-H, Zhang F, Li Y-M, Chen H. Helicobacter pylori and portal hypertensive gastropathy. Hepatobiliary Pancreat Dis Int. (2018) 17:578\u201380.", "ArticleIdList": ["30414714"]}, {"Citation": "Elwakil R, Al Breedy AM, Gabal HHA. Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study. Hepatol Int. (2016) 10:965\u201373. 10.1007/s12072-016-9711-z", "ArticleIdList": ["10.1007/s12072-016-9711-z", "26932843"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "22"}, {"Year": "2022", "Month": "4", "Day": "27"}, {"Year": "2022", "Month": "7", "Day": "8", "Hour": "3", "Minute": "2"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["35801205", "PMC9254718", "10.3389/fmed.2022.902255"]}}], "PubmedBookArticle": []}